Kremers Urban launches rabeprazole sodium tablets
PRINCETON, N.J. — Kremers Urban Pharmaceuticals, a subsidiary of UCB, announced the launch of rabeprazole sodium delayed-release tablets. The drug is used to treat gastroesophageal reflux disease in adults and adolescents, according to the FDA.
The product is the bioequivalent to Aciphex from Eisai. Kremers Urban rabeprazole sodium delayed-release tablets are available in 20-mg strength in both 30- and 90-count bottles.
Poll: Drug stores among favorite place to buy groceries
NEW YORK — A recent poll of U.S. millennial, gen X and Baby Boomer consumers found that traditional retail categories are increasingly blurring, and more and more shoppers are turning to drug stores to buy groceries.
Retail design firm King Retail Solutions conducted the fall 2013 study among more than 1,200 consumers.
Shoppers were polled on their past shopping habits, current shopping attitudes, decision-making factors and top preferred retailers (Target, Walmart, Walgreens and Costco topped the list in each category), all as relates to purchasing these types of goods from a non-traditional source (e.g., purchasing a fresh meal from a pharmacy or a hair cut from a big box store).
Among the findings: such pharmacy retailers as Walgreens and CVS/pharmacy were listed among the “Top 20 favorite places to buy groceries (that aren’t grocery stores).”
NCPA announces endorsement of bill aimed at curbing Rx drug abuse
ALEXANDRIA, Va. — Legislation recently introduced by U.S. Rep. Tom Marino, R-Pa., which is intended to reduce the abuse of prescription drugs by fostering greater collaboration among stakeholders and implementing new safeguards, has received the endorsement of the National Community Pharmacists Association.
“America is in the throes of a prescription drug abuse crisis,” said NCPA CEO B. Douglas Hoey. “No one wants to address it more than community pharmacists, who are the experts in the proper use of prescription medication and who understand the consequences of drug diversion and abuse. We commend Representative Marino for his leadership in this area. Our support for this legislation reflects the constructive approach that NCPA has taken to working with federal and state policymakers, law enforcement and all stakeholders in support of effective, practical solutions to the prescription drug abuse epidemic, while preserving access to medication for those with legitimate health needs.”
The Ensuring Patient Access and Effective Drug Enforcement Act (H.R. 4069) would amend the Controlled Substances Act and implement the following reforms:
- Require manufacturers and distributors registered with the Drug Enforcement Administration to ensure that their employees with access to controlled substances satisfy criminal background checks and drug tests; and
- Establish a Combating Prescription Drug Abuse Working Group of federal and state officials as well as private sector stakeholders dedicated to examining ways to reduce abuse and diversion. Members of the panel would include a representative of community pharmacy. It would also be a forum by which concerns of independent community pharmacies may be addressed.
In presentations to Congress, the FDA and DEA, NCPA has recommended steps to combat prescription drug abuse while protecting patients. They include utilization of electronic prescription drug monitoring programs and tracking systems, more effective education of prescribers, shutting down rogue pain clinics, offering more disposal options for excess medications and more scrutiny of controlled substances delivered by mail order pharmacies.